Mounjaro Approval For Weight Loss 2024. The shortage is anticipated to continue well into 2024, leaving doctors and patients in limbo. All of those listed as having limited availability will remain that way through march 2024.
A dose of eli lilly’s (lly.n) diabetes drug mounjaro has limited availability through february 2024, according to the u.s. In that study of more than 2,500 adults with obesity, people taking 5 milligrams of mounjaro for 72 weeks (about a year and a half) lost 15% of their body weight on average.
The Shortage Is Anticipated To Continue Well Into 2024, Leaving Doctors And Patients In Limbo.
All of those listed as having limited availability will remain that way through march 2024.
A Dose Of Eli Lilly's (Lly.n) Diabetes Drug Mounjaro Has Limited Availability Through February 2024, According To The U.s.
Regulators announced wednesday.related video above:
Mounjaro Is A Diabetes Drug That Is Now Approved For Weight Loss Under A New Name, Zepbound.
Images References :
Eli Lilly, The Maker Of The Drug Mounjaro, Said Thursday It.
The drug, called mounjaro for diabetes, will be called zepbound for weight.
In That Study Of More Than 2,500 Adults With Obesity, People Taking 5 Milligrams Of Mounjaro For 72 Weeks (About A Year And A Half) Lost 15% Of Their Body Weight On Average.
A popular drug currently approved to treat type 2 diabetes could soon also be approved for weight loss.